Donors at risk: Proteinuria

Nephrology

Volumn 15, Issue SUPPL. 1, 2010, Pages

  Boudville, Neil ^a   Kanellis, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; CREATININE BLOOD LEVEL; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MICROALBUMINURIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; SHORT SURVEY; URINARY EXCRETION; ARTICLE; NEPHRECTOMY; PRACTICE GUIDELINE;

HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; NEPHRECTOMY; PROTEINURIA;

EID: 77950505881     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01218.x     Document Type: Short Survey

References (18)

1. Diercks GF, Hillege HL, van Boven AJ et al. Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes. J Am Coll Cardiol 2002 40 : 1401.
2. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 286 : 421 426.
3. Gerstein HC, Mann JF, Pogue J et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 2000 23 (Suppl 2 B35 9.
4. Hillege HL, Janssen WM, Bak AA et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001 249 : 519 526.
5. Iseki K, Iseki C, Ikemiya Y et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996 49 : 800 805. (Pubitemid 26093091)
6. Ruggenenti P, Perna A, Mosconi L et al. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. 'Gruppo Italiano di Studi Epidemiologici in Nefrologia' (GISEN). Kidney Int 1998 53 : 1209 1216.
7. Garg AX, Muirhead N, Knoll G et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006 70 : 1801 1810.
8. D'Almeida P, Keitel E, Bittar A et al. Long-term evaluation of kidney donors. Transplant Proc 1996 28 : 93 4.
9. Williams SL, Oler J, Jorkasky DK. Long-term renal function in kidney donors: A comparison of donors and their siblings. Ann Intern Med 1986 105 : 1 8.
10. Mathillas O, Attman PO, Aurell M et al. Glomerular filtration rate, hypertension and proteinuria after renal ablation: a long-term follow-up study in kidney donors. Scand J Urol Nephrol Suppl 1988 108 : 49 55.
11. Levine M, Walter S, Lee H et al. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994 271 : 1615 1619.
12. Tsinalis D, Binet I, Steiger J et al. Can 'borderline' living kidney donors (BLKD) be used safely for transplantation? [abstract Kidney Blood Press Res 1999. 22 : 388 389.
13. Atkins RC, Briganti EM, Zimmet PZ et al. Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant 2003 18 : 2170 2174.
14. Leischner MP, Naratadam GO, Hou SH et al. Evaluation of proteinuria in healthy living kidney donor candidates. Transplant Proc 2006 38 : 2796 2797.
15. Goldfarb DA, Matin SF, Braun WE et al. Renal outcome 25 years after donor nephrectomy. J Urol 2001 166 : 2043 2047.
16. Fehrman-Ekholm I, Duner F, Brink B et al. No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up. Transplantation 2001 72 : 444 449.
17. Watnick TJ, Jenkins RR, Rackoff P et al. Microalbuminuria and hypertension in long-term renal donors. Transplantation 1988 45 : 59 65.
18. Sobh M, Nabeeh A, el-Din AS et al. Long-term follow-up of the remaining kidney in living related kidney donors. Int Urol Nephrol 1989 21 : 547 553.